ECD Life Sciences publishes regular commentary on drug development, FDA regulatory affairs, and U.S. agent services for international sponsors. Posts are written by Daniel Weiss, MD, principal of ECD Life Sciences, drawing on more than 20 years of industry experience in IND strategy, early clinical development, and regulatory operations. Follow ECD Life Sciences on LinkedIn for the latest updates.
